Microplastics Found in 90% of Prostate Cancer Tissue Samples, at Higher Levels Inside Tumors
Microplastics are no longer a trace contaminant in the human body. Studies have now detected them in blood, lung tissue, the placenta, breast milk, the colon, and multiple other organs. Whether they affect health, and how, remains poorly understood - a gap between detection and mechanism that has so far produced more concern than clarity.
A small but carefully designed study from NYU Langone Health adds a new location to the list: prostate tumors. The research, led by investigators at NYU Langone Health, its Perlmutter Cancer Center, and its Center for the Investigation of Environmental Hazards, found microplastic particles in 9 of 10 patients with prostate cancer. More notably, the concentrations found inside tumor tissue were measurably higher than those in adjacent noncancerous tissue from the same patients.
What was measured and how
The study analyzed tissue samples collected from 10 patients with confirmed prostate cancer. Researchers examined matched pairs of samples - tumor tissue and nearby noncancerous prostate tissue from the same patient - to allow within-patient comparisons that control for individual variation in plastic exposure history.
Plastic particles were identified in 90% of the tumor samples. The concentration difference between tumor and adjacent normal tissue was the study's most striking quantitative finding. Whether that difference reflects preferential accumulation of microplastics in tumor tissue, active uptake by cancer cells, or some other mechanism is not established by the current data.
The types of plastics detected were not specified in detail in the public announcement, but the broader literature on microplastics in human tissue identifies polyethylene, polypropylene, and polystyrene as common findings, sourced from food packaging, synthetic textiles, cosmetics, and household products.
How plastics enter the body
Human plastic exposure occurs through multiple routes. Particles from food packaging and containers can be ingested directly, particularly when plastic is heated, as in microwave use. Synthetic textiles release fibers during washing and wear. Industrial and agricultural emissions contribute to airborne plastic particles that enter the body through inhalation. Some compounds in plastics - phthalates, bisphenols, and other additives - are absorbed through the skin.
Once in the bloodstream or lymphatic system, particles can accumulate in tissues. Studies have found microplastics in coronary arteries, where their presence was associated with increased cardiovascular event risk in a 2024 study - though again, causation was not established. The prostate findings are consistent with a pattern of systemic distribution rather than selective deposition in one organ.
Prostate cancer context
Prostate cancer is the most common cancer among American men according to the American Cancer Society, with an estimated 288,000 new diagnoses and approximately 34,000 deaths in 2023. The disease's etiology involves well-established risk factors including age, family history, and race, but environmental and dietary contributors remain an active area of investigation.
The NYU Langone study is designed as exploratory research - identifying whether microplastics are present in prostate tumor tissue and characterizing the distribution pattern. It does not establish that microplastics cause prostate cancer, accelerate tumor growth, or worsen clinical outcomes. Those questions would require much larger studies with longer follow-up, rigorous exposure assessment, and comparison groups not limited to cancer patients.
Why the limitations matter
Ten patients is a very small sample for drawing conclusions about any biological phenomenon, let alone cancer causation. Single-center studies have limited generalizability; patient selection at a major cancer center may not reflect the prostate cancer population broadly. The study analyzed tissue samples at a single point in time, not longitudinal tissue from the same patients over years, which means it cannot address whether plastic accumulation preceded tumor development or followed it.
The higher concentration of microplastics inside tumors compared to adjacent tissue is the finding most in need of mechanistic explanation. Tumors have altered blood supply, different inflammatory environments, and different cellular uptake characteristics compared to normal tissue. Any of these differences could contribute to differential plastic accumulation independent of any causal role for the plastics themselves.
The study is the kind of preliminary observation that motivates larger, better-powered investigations. Its value is in establishing that the particles are there and that their distribution is not random across tissue types - not in establishing why.